This Hematology Research Training Program is committed to training physician-scientists for careers in academic medicine and hematology research. Our program strives to balance sufficient structure to ensure rigor of the training experience with sufficient flexibility to ensure that individual trainee career goals can be met. We accomplish this by bringing together a Fellowship Program and Research Training Program that are closely integrated, in a rich intellectual environment with a supportive resource-rich infrastructure, with a faculty that is highly-qualified and enthusiastic and dedicated to development of young investigators. Our faculty roster includes twenty-seven senior mentors and six Junior mentors. Their areas of expertise and research interests encompass: Biomedical Ethics, Transfusion Medicine, Vascular Biology (including endothelial biology and angiogenesis, hemostasis and thrombosis, blood cell biology and immunology, and sickle disease), and Stem Cell Malignancy (including hematologic malignancies, hematopoiesis, stem cell biology, marrow transplantation, and aspects of oncology that are directly relevant to hematologic disease such as signal transduction, cell cycle control, adhesion science). This Training Grant now has new leadership, and a number of changes have already been made in the Program?s structure, style, emphasis and philosophy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007062-26
Application #
6454576
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Mondoro, Traci
Project Start
1982-07-01
Project End
2007-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
26
Fiscal Year
2002
Total Cost
$398,857
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Goldberg, Michael F; Roeske, Elizabeth K; Ward, Lauren N et al. (2018) Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells. Immunity 49:1090-1102.e7
Don Yun, Hyun; Felices, Martin; Vallera, Daniel A et al. (2018) Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells. Blood Adv 2:1580-1584
Shaban, Nadine M; Shi, Ke; Lauer, Kate V et al. (2018) The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism. Mol Cell 69:75-86.e9
Davis, Zachary B; Vallera, Daniel A; Miller, Jeffrey S et al. (2017) Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy. Semin Immunol 31:64-75
Ranganathan, Parvathi; Ngankeu, Apollinaire; Zitzer, Nina C et al. (2017) Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding. J Immunol 198:2500-2512
Osborn, Mark J; Webber, Beau R; McElmurry, Ronald T et al. (2017) Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology. J Inherit Metab Dis 40:281-289
Kramer, Ashley C; Blake, Amanda L; Taisto, Mandy E et al. (2017) Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance. Stem Cell Reports 9:770-778
Smith, Michelle J; Reichenbach, Dawn K; Parker, Sarah L et al. (2017) T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. JCI Insight 2:
Angelos, Mathew G; Ruh, Paige N; Webber, Beau R et al. (2017) Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells. Blood 129:3428-3439
Pomeroy, E J; Lee, L A; Lee, R D W et al. (2017) Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia. Oncogene 36:3263-3273

Showing the most recent 10 out of 102 publications